CMS expands coverage of lung cancer screening with low dose computed tomography

On February 10, 2022, CMS announced a national coverage determination that expands coverage for lung cancer screening with low-dose computed tomography (LDCT). This aims to improve health outcomes for people with lung cancer. It expands eligibility for people with Medicare to get lung cancer screening with LCDT in two ways:

You need to be logged in to view the rest of the content. Please . Not a Member? Join Us

Discover more from Doctor Trusted

Subscribe to get the latest posts sent to your email.

Discover more from Doctor Trusted

Subscribe now to keep reading and get access to the full archive.

Continue reading